Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2), S400-S403
- https://doi.org/10.1086/520587
Abstract
The survival of 7 of 8 patients with Ebola virus (EBOV) infection after transfusions of convalescent-phase blood during a 1995 outbreak of EBOV infection is frequently cited as evidence that passive immunotherapy is a viable treatment option. To test whether whole-blood transfusions were more efficacious than passively administered immunoglobulins or monoclonal antibodies, we transfused convalescent-phase blood from EBOV-immune monkeys into naive animals shortly after challenge with EBOV. Although passively acquired antibody titers comparable to those associated with effective vaccination were obtained, all monkeys that had received transfusions succumbed to infection concurrently with control monkeys. These data cast further doubt on the value of passive immunotherapy for the treatment of EBOV infection.Keywords
This publication has 12 references indexed in Scilit:
- Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in MonkeysPLoS Pathogens, 2007
- Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPsPLoS Medicine, 2006
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primatesNature, 2003
- Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human AntibodyJournal of Virology, 2002
- Evaluation in Nonhuman Primates of Vaccines against Ebola VirusEmerging Infectious Diseases, 2002
- Haematological, Biochemical and Coagulation Changes in Mice, Guinea-pigs and Monkeys Infected with a Mouse-adapted Variant of Ebola Zaire VirusJournal of Comparative Pathology, 2001
- Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent PatientsThe Journal of Infectious Diseases, 1999
- Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995: Determinants of SurvivalThe Journal of Infectious Diseases, 1999
- Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus InfectionsThe Journal of Infectious Diseases, 1999
- A case of Ebola virus infection.BMJ, 1977